THC

Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis

Retrieved on: 
Wednesday, February 28, 2024
Honey, AB, Cultivar, TSX, ACB, Health, Patient, THC, Partnership, Nursing

EDMONTON, AB, Feb. 28, 2024 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, today announced the partnership of Aurora Medicine UK Ltd with Script Assist, a cutting-edge medical cannabis prescription platform in the UK.

Key Points: 
  • EDMONTON, AB, Feb. 28, 2024 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, today announced the partnership of Aurora Medicine UK Ltd with Script Assist, a cutting-edge medical cannabis prescription platform in the UK.
  • Designed to support UK patients on their journey of well-being, the Script Assist platform provides access to high quality medication through their portal.
  • Script Assist will make available an extensive range of medical cannabis products from Aurora's leading portfolio of products.
  • The full range of Aurora's medical cannabis products will be available for patients through prescription by all private doctors and clinics using the platform, transforming the UK medical cannabis prescription journey.

Bristow and The Helicopter Company Form Strategic Partnership to Explore Advanced Air Mobility Opportunities

Retrieved on: 
Tuesday, February 27, 2024
Aircraft, Aviation, Helicopter, AAM, Certification, THC, Public Investment Fund, MOU, Kingdom, Partnership, Arms industry

The two companies plan to work together on advanced air mobility (AAM) initiatives in the Kingdom of Saudi Arabia as well as other collaborative vertical lift endeavors.

Key Points: 
  • The two companies plan to work together on advanced air mobility (AAM) initiatives in the Kingdom of Saudi Arabia as well as other collaborative vertical lift endeavors.
  • Together with Bristow, we will prove that everything is possible in aviation with the right partner."
  • "Bristow has collaborations with multiple leading AAM manufacturers to provide critical safety, operational, certification, and logistics expertise.
  • This agreement outlines a framework for Bristow and THC to adopt these new technologies, quickly and effectively, to strengthen a growing aviation ecosystem within Saudi Arabia."

Phylos® and People Science® Announce Results of IRB-Backed Controlled Research Study on the Energizing Effects of THCV

Retrieved on: 
Tuesday, February 27, 2024
Research, Doctor of Philosophy, MD, THCV, Exercise, Nature, IRB, Kanha, Fatigue, Ozone, Tunnel, THC, Motivation, Cannabis, Science, GSD, Tunnel vision, Hunger, Animal feed

PORTLAND, Ore., Feb. 27, 2024 /PRNewswire/ -- Cannabis genetics company Phylos®, along with People Science, a direct-to-consumer scientific research and technology company, has conducted an IRB-approved, double-blind clinical research study on the effects of rare cannabinoid tetrahydrocannabivarin (THCV). Results of the study found that Natural Natural™ THCV by Phylos significantly increased energy, activity, motivation, and well-being compared to placebo, without the fatigue and munchies associated with THC consumption.

Key Points: 
  • Results of the study found that Natural Natural ™ THCV by Phylos significantly increased energy, activity, motivation, and well-being compared to placebo, without the fatigue and munchies associated with THC consumption.
  • "This study signifies a pivotal moment for the cannabis industry in understanding the effect of THCV in combination with THC," according to Alisha Holloway, PhD, Chief Scientific Officer at Phylos.
  • "The Natural Natural THCV study allows us to leverage our exceptional plants in the advancement of targeted cannabis products, and to chart new territories in understanding the efficacy of natural cannabinoids."
  • Research participants ingested unmedicated placebo gummies, THC-only gummies, and gummies infused with extract from Get Sh!t Done™ (GSD), a THCV-dominant plant bred by Phylos.

CANOPY GROWTH LAUNCHES NEW PRE-ROLLS FROM 7ACRES AND HIWAY

Retrieved on: 
Thursday, February 22, 2024
TSX, Canopy Growth, Burn, Roadie, Cannabis, THC, Tea

SMITHS FALLS, ON, Feb. 22, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, today announced the introduction of five new pre-roll products across the Company's adult-use cannabis portfolio from brands 7ACRES and Hiway.

Key Points: 
  • SMITHS FALLS, ON, Feb. 22, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, today announced the introduction of five new pre-roll products across the Company's adult-use cannabis portfolio from brands 7ACRES and Hiway.
  • "Forging ahead with our commitment to innovation, we're excited to offer new pre-roll offerings that meet consumers across a range of occasions and price points," said Dave Paterson, President, Canada, Canopy Growth.
  • 7ACRES Smooth Burners 2x0.7g cannabis pre-rolls feature a hybrid designed to deliver the smoothest and slowest burn.
  • For those looking for high-quality in a value package, Hiway Water Hash Infused pre-rolls 3x0.5g deliver the goods.

Celebrate Self-Care with Rare Cannabinoid Company's Exclusive Offers On CBG, THC, CBC & CBD Gummies & Oils

Retrieved on: 
Wednesday, February 21, 2024
CBC, THCV, Sleep, CBN, Cannabinoid, CBG, THC, Oil, MCT, Coconut oil, Dietary supplement

HONOLULU, Feb. 21, 2024 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company invites you to indulge in the ultimate self-care experience with their exclusive offers on a wide range of cannabinoid products this month. Whether you're seeking relief from soreness, stress, or simply aiming to elevate your well-being, Rare Cannabinoid Company has something special for everyone.

Key Points: 
  • From CBG gummies to oils, including variants with or without CBD and THC, Rare Cannabinoid Company ensures a comprehensive selection to cater to diverse preferences and wellness goals.
  • HONOLULU, Feb. 21, 2024 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company invites you to indulge in the ultimate self-care experience with their exclusive offers on a wide range of cannabinoid products this month.
  • THC + CBG Gummies - These hemp gummies contain the same ingredients as the brand's CBG gummies plus 2.5mg Delta-9-THC per gummy.
  • From a diverse array of rare cannabinoid isolate oils to full-spectrum hemp Delta-9-THC gummies, Rare Cannabinoid Company provides an extensive apothecary tailored to meet your unique needs.

Kona Gold Beverages, Inc. Unveils Exciting Rebranding: Introducing HighDrate D9 Seltzer Drink Line

Retrieved on: 
Tuesday, February 20, 2024
Citric acid, KGKG, Colada, Growth, Relaxation, THC, Taste, Drink, Blue Raspberry, Soft drink

ROCKLEDGE, Fla., Feb. 20, 2024 /PRNewswire/ -- Kona Gold Beverages, Inc. (OTCPK: KGKG), a dynamic holding company specializing in product development within the better-for-you and functional beverage sector, is thrilled to announce a significant transformation in its product lineup with the launch of HighDrate D9 Seltzer Drink line. This rebranding marks a strategic shift towards innovation and meeting evolving consumer preferences.

Key Points: 
  • The HighDrate line has cultivated an incredibly loyal following among consumers, demonstrating its potential as a valuable asset for Kona Gold.
  • The new HighDrate D9 Seltzer Drink line replaces the HighDrate's CBD Energy Waters, offering consumers a refreshing and exhilarating experience with each sip.
  • Moreover, HighDrate D9 Seltzer Drinks uphold Kona Gold Beverages, Inc.'s commitment to ethical sourcing and consumer satisfaction.
  • For more information about HighDrate D9 Seltzer Drinks and Kona Gold Beverages, Inc., please visit https://konagoldbeverage.com/

4Front Ventures Unveils Mission: A Signature Cannabis Experience

Retrieved on: 
Tuesday, February 20, 2024
Collection, Breeding, Mission, Dispensary, THC, Cannabis, Venture, Slushy

Introduces new Premium Flower Brand Mission Cannabis: now available at all Mission Dispensaries in Massachusetts and coming soon to Illinois

Key Points: 
  • Introduces new Premium Flower Brand Mission Cannabis: now available at all Mission Dispensaries in Massachusetts and coming soon to Illinois
    PHOENIX, Feb. 20, 2024 /PRNewswire/ - 4Front Ventures Corp .
  • (CSE: FFNT) (OTCQX: FFNTF) ("4Front" or the "Company"), a vertically integrated, multi-state cannabis operator and retailer,  today is proud to announce the launch of Mission Cannabis, its marquee flower brand.
  • Andrew Thut, CEO of 4Front Ventures, shared his excitement about the signature brand: "At 4Front, we continually aim to innovate and command the market by delivering high-caliber, customer-oriented cannabis products.
  • Mission flower provides a balanced cannabis experience that does not compromise on quality or affordability."

Legal Help in Colorado, P.C. Achieves Monumental Victory in Personal Injury Case Involving Catastrophic Motor Vehicle Collision

Retrieved on: 
Monday, February 19, 2024
Safety, Injury, Liver, Counsel, Crash, P.C, Insurance, Policy, THC

BOULDER, Colo., Feb. 19, 2024 /PRNewswire/ -- In a notable triumph for justice and accountability, Legal Help in Colorado, P.C.

Key Points: 
  • BOULDER, Colo., Feb. 19, 2024 /PRNewswire/ -- In a notable triumph for justice and accountability, Legal Help in Colorado, P.C.
  • , a premier personal injury law firm dedicated to championing the rights of those harmed by the wrongful actions of others, proudly announces a decisive victory in a complex case involving a catastrophic motor vehicle collision.
  • This case ended in a significant award well above insurance policy limits for the plaintiff, Makayla Stein, marking a pivotal moment in the enforcement of road safety and legal responsibility in Colorado.
  • "This case stands as a testament to our unwavering commitment to seeking justice for the victims of impaired and dangerous drivers.

Sweetspot Farms Opens New Dispensary Location in West Hartford, Connecticut

Retrieved on: 
Monday, February 19, 2024
Cannabis, Farm, Patient, Park Road, THC, Prospect Avenue, MD, Hospital

WEST HARTFORD, Conn., Feb. 19, 2024 /PRNewswire/ -- Sweetspot Farms ("Sweetspot" or the "Company"), a growing craft cannabis company with state-of-the-art dispensaries and sustainability focused cultivation operations situated throughout the Northeast and Mid-Atlantic, today announced the successful grand opening of its latest dispensary location at 2 Park Road in West Hartford, Connecticut 06119.

Key Points: 
  • WEST HARTFORD, Conn., Feb. 19, 2024 /PRNewswire/ -- Sweetspot Farms ("Sweetspot" or the "Company"), a growing craft cannabis company with state-of-the-art dispensaries and sustainability focused cultivation operations situated throughout the Northeast and Mid-Atlantic, today announced the successful grand opening of its latest dispensary location at 2 Park Road in West Hartford, Connecticut 06119.
  • As with all Sweetspot dispensaries, this new West Hartford location is staffed by experienced and educated budtenders.
  • "Connecticut is an exciting market," said Jason Webski, Sweetspot's co-founder, CEO, and Connecticut born native.
  • This new dispensary marks the Company's first location in CT, with another dispensary recently approved to open in Stamford.

IGC Pharma Reports Third Quarter Fiscal 2024 Results

Retrieved on: 
Saturday, February 17, 2024
Science, Research, Natural Resources, Pharmaceutical, Alternative Medicine, Health, Mental Health, Clinical Trials, Artificial intelligence, Central nervous system disease, Pain, IGC, Loss, GMP, Composition, Treating, Cannabinoid, University, PPE, Certification, Administration, Patent, Patient, CBD, THC, LMP, Agitation, American University, Dementia, Bank statement, Somatic symptom disorder, Human, European Patent Convention, Pharmaceutical industry

IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the third fiscal quarter of 2024 ended December 31, 2023 (Q3 FY 2024).

Key Points: 
  • IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the third fiscal quarter of 2024 ended December 31, 2023 (Q3 FY 2024).
  • IGC is optimistic that the success in Mexico can pave the way for additional patent approvals in the U.S. and Europe.
  • We are working hard to obtain interim results in 2024.
  • With modest pricing and conservative market penetration IGC-AD1 can potentially be a block buster drug,” said Ram Mukunda, CEO of IGC Pharma.